Diurnal Group PLC
LSE:DNL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Diurnal Group PLC
Diurnal Group PLC
Cash & Cash Equivalents
Diurnal Group PLC
Cash & Cash Equivalents Peer Comparison
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Diurnal Group PLC
LSE:DNL
|
Cash & Cash Equivalents
£16.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash & Cash Equivalents
$128m
|
CAGR 3-Years
161%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash & Cash Equivalents
$239.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash & Cash Equivalents
$457m
|
CAGR 3-Years
33%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash & Cash Equivalents
£442.6m
|
CAGR 3-Years
51%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash & Cash Equivalents
£42m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
See Also
What is Diurnal Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
16.5m
GBP
Based on the financial report for Jun 30, 2022, Diurnal Group PLC's Cash & Cash Equivalents amounts to 16.5m GBP.
What is Diurnal Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
13%
Over the last year, the Cash & Cash Equivalents growth was -52%. The average annual Cash & Cash Equivalents growth rates for Diurnal Group PLC have been 22% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
